Trusted Resources: Education
Scientific literature and patient education texts
Systematic Literature Review to Assess the Cost and Resource Use Associated With Spinal Muscular Atrophy Management
source: PharmacoEconomics
year: 2021
authors: Paracha N,Hudson P,Mitchell S,Sutherland CS
summary/abstract:Spinal muscular atrophy (SMA) is a severe neuromuscular disease that is inherited in an autosomal recessive manner with an estimated incidence of 1 in 10,000 live births. The traditional classification of SMA includes five types (Types 0-4 SMA) based on patient age at disease onset and the highest motor milestone achieved. Spinal muscular atrophy leads to progressive muscle denervation, skeletal muscle atrophy and loss of motor function and ambulation, though phenotypes vary along a disease continuum. Regardless of disease severity, or access to treatment, a multidisciplinary approach to care is required to ease the burden of disease. To date, limited global data exist regarding the cost and resource use associated with SMA management.
organization: F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124 Building 001/OG13, CH, 4070, Basel, Switzerland.DOI: 10.1007/s40273-021-01105-7
read more
Related Content
-
Sofia’s Story – Johns Hopkin’sOn the morning of Friday, Aug. 23, 2019,...
-
Looking After Your Child Who Has Had a Recent Diagnosis of SMA Type 3Your child should receive care from memb...
-
STR1VE-EU Trial Shows Efficacy of Onasemnogene Abeparvovec in Spinal Muscular AtrophyOnasemnogene abeparvovec gene replacemen...
-
Detection of Spinal Muscular Atrophy Patients Using Dried Saliva SpotsSpinal muscular atrophy (SMA) is a lower...
-
H-NMR-Based Metabolic Profiling Identifies Non-Invasive Diagnostic and Predictive Urinary Fingerprints in 5q Spinal ...5q spinal muscular atrophy (SMA) is a di...
-
Muscular Dystrophy AssociationMDA's legacy of progress has always star...
-
Targeted NGS Seen as Best When Screening for SMA and Its CarriersTargeted next generation sequencing (NGS...